Answers are grounded in this paper and cite their sources.
Lycium barbarum L. Solanaceae a traditi onal medicinal plant of China has been accorded a very high safety value. It has been known to possess various benefi cial eff ects like reducti on of blood glucose and serum lipids in alloxan-induced diabetes models, anti -ageing, immuno-modulati ng, anti -cancer, anti -fati gue, and male ferti lity-facilitatory acti ons. The present study is an att empt to explore the hypolipidemic eff ects of powdered L. barbarum in high fat diet-induced model of hyperlipidemia. Powdered L. barbarum fruit extract (250mg/kg and 500mg/kg) was administered to Wistar albino rats fed on a cholesterol-rich high-fat diet for 45 days. The eff ects were compared with the standard drug atorvastati n (10 mg/kg/day, oral). Aft er 30 days of treatment, the lipid profi le of the blood samples of the experimental rodents was evaluated.The data presented as mean±SEM were analysed using one-way ANOVA followed by Tukey’s post hoc test. P<0.05 was considered as stati sti cally signifi cant. In the present study, L. barbarum powdered extract showed a signifi cant reducti on in the total cholesterol, triglycerides and very low density lipoprotein-cholesterol levels at both the doses employed (p<0.05). However, reducti on in low density lipoprotein-cholesterol levels was signifi cant (p<0.05) only at the dose of 500 mg/kg when compared to the standard drug group. The increase in high-density lipoprotein levels was signifi cant only at 250 mg/kg. The data thus suggests the positi ve anti -hyperlipidemic acti vity of L. barbarum in high fat diet-induced hyperlipidemia in rats.
No takes yet. Share an insight, caveat, or question.
Pai et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: